DCF — MEMORIAL HOSPITAL FOR CANCER AND ALL
Enterprise Value: $-3.8B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.8B
Enterprise Value
$-1.3B
PV of Cash Flows
$-2.6B
PV of Terminal Value
$-4.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $4.5B | $-201.3M | -4.0% | $-390.7M | $-355.2M |
| Year 2 | $4.6B | $-161.3M | -3.0% | $-356.4M | $-294.5M |
| Year 3 | $4.7B | $-118.7M | -2.0% | $-319.6M | $-240.1M |
| Year 4 | $4.9B | $-97.8M | -2.0% | $-304.7M | $-208.1M |
| Year 5 | $5.0B | $-88.1M | -2.0% | $-301.3M | $-187.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.8B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$4.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999995395694
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5